Prioritization of potential causative genes for schizophrenia in placenta

Nat Commun. 2023 May 15;14(1):2613. doi: 10.1038/s41467-023-38140-1.

Abstract

Our earlier work has shown that genomic risk for schizophrenia converges with early life complications in affecting risk for the disorder and sex-biased neurodevelopmental trajectories. Here, we identify specific genes and potential mechanisms that, in placenta, may mediate such outcomes. We performed TWAS in healthy term placentae (N = 147) to derive candidate placental causal genes that we confirmed with SMR; to search for placenta and schizophrenia-specific associations, we performed an analogous analysis in fetal brain (N = 166) and additional placenta TWAS for other disorders/traits. The analyses in the whole sample and stratifying by sex ultimately highlight 139 placenta and schizophrenia-specific risk genes, many being sex-biased; the candidate molecular mechanisms converge on the nutrient-sensing capabilities of placenta and trophoblast invasiveness. These genes also implicate the Coronavirus-pathogenesis pathway and showed increased expression in placentae from a small sample of SARS-CoV-2-positive pregnancies. Investigating placental risk genes for schizophrenia and candidate mechanisms may lead to opportunities for prevention that would not be suggested by study of the brain alone.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • COVID-19* / metabolism
  • Female
  • Humans
  • Placenta / metabolism
  • Pregnancy
  • SARS-CoV-2
  • Schizophrenia* / genetics
  • Schizophrenia* / metabolism
  • Trophoblasts / metabolism